News, Analysis & Insights on Nutrition, Supplements, and Health
The FDA is proposing to revoke a health claim on the relationship between soy protein and reduced risk of heart disease, citing “inconsistent findings” from research published since the claim was authorized in 1999.
Norwegian scientific consulting firm Orivo has announced a plan in conjunction with supplier GC Rieber Oils to refine its testing technology to be able to verify the authenticity of concentrated fish oils.
The US International Trade Commission has decided not to hear a case in which the fish oil drug maker Amarin sought to prevent the import of some omega-3 dietary supplements.
Researchers in Serbia found that diabetic lab rats orally administered with the probiotic Lactobacillus paraplantarum BGCG11 experienced a reduced level of DNA damage in the liver and kidney, compared to control rats that didn’t receive probiotics.
Disrupted copper metabolism may be linked to progression of non-alcoholic fatty liver disease (NAFLD), suggests a recent review in Nutrients.
The plant that gave the world tequila and mezcal may have prebiotic health benefits, according to researchers from Mexico and Germany.
Nutrasource Diagnostics Inc. is set to launch a certification program to test probiotic brands, helping consumers to make informed choices for their probiotic purchases.
Israeli flavour and fine ingredients firm Frutarom are now the owners of nutritional ingredients specialists Enzymotec in a €144m ($168m) deal for the remaining 81% of company shares.